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Gamma-herpesviruses (gHVs) are widespread
oncogenic pathogens that chronically infect circu-
lating lymphocytes. How they subvert the immune
check-point function of the spleen to promote
persistent infection is not clear. We show that Murid
Herpesvirus-4 (MuHV-4) enters the spleen by infect-
ing marginal zone (MZ) macrophages, which pro-
vided a conduit to MZ B cells. Relocation of MZ B
cells to the white pulp allowed virus transfer to follic-
ular dendritic cells. From here the virus reached
germinal center B cells to establish persistent infec-
tion. Mice lacking MZ B cells, or treated with a sphin-
gosine-1-phosphate receptor agonist to dislocate
them, were protected against MuHV-4 colonization.
MuHV-4 lacking ORF27, which encodes a glycopro-
tein necessary for efficient intercellular spread, could
infect MZ macrophages but was impaired in long-
term infection. Thus, MuHV-4, a gHV, exploits normal
immune communication routes to spread by serial
lymphoid/myeloid exchange.
INTRODUCTION
The gHVs persist in lymphocytes and cause lymphoid cancers.
However, we know little about how lymphoid infection is estab-
lished, because this precedes clinical presentation. In vitro
Epstein-Barr virus (EBV) transforms primary B cells. However,
in vivo it is found mainly in germinal center (GC)-derived resting
memory B cells (Thorley-Lawson et al., 2008), arguing that infec-
tion is tightly linked to host functions. The involvement of other
cell types is suggested by EBV colonizing epithelial, NK, and
T cell cancers (George et al., 2012). The Kaposi’s sarcoma-asso-
ciated herpesvirus (KSHV) also infects a range of cell types (Ga-
nem, 2006). Thus, B cell transformation may not reflect the full
complexity of host colonization.
Analyses of EBV and KSHV are hampered by their narrow spe-
cies tropisms. MuHV-4 (Nash and Sunil-Chandra, 1994; Black-
man and Flan˜o, 2002; Stevenson et al., 2009; Barton et al.,Cell2011), which is genetically similar to KSHV, provides a more
tractable experimental route to understanding how gHVs estab-
lish chronic infection. Like EBV, it drives B cell proliferation in
splenic GCs and persists in memory B cells. MuHV-4 enters
new hosts via the olfactory neuroepithelium (Milho et al., 2012)
or genital tract (Franc¸ois et al., 2013), dendritic cells (DCs) take
it to lymph nodes (LNs) (Gaspar et al., 2011), and from there it
reaches the spleen. The spleen normally limits vascular path-
ogen spread, so its infection is a key event in host colonization.
Intranasal (i.n.) MuHV-4 requires B cells to reach the spleen
(Usherwood et al., 1996). However, once there it infects newly
formed, marginal zone (MZ) and GC B cells (Marques et al.,
2003), which are unlikely to derive from LN memory B cells.
Therefore, B cell recirculation and proliferation do not explain
all the features of splenic infection.
Here we show that MuHV-4 enters the spleen by infecting
MZ macrophages. It then reached MZ B cells. These relocated
to the white pulp (WP) and transferred virions to follicular DCs.
Infected B cells then appeared in WP GCs. These data establish
a paradigm of gHV spread along immune communication path-
ways and suggest that targeting intercellular exchanges could
help to limit chronic infection.
RESULTS
MuHV-4 Transits from LN to Spleen via a lysM+ Cell
Inserting loxP sites into herpesvirus genomes can reveal their
passage history by recombination in cre transgenic mice (Sacher
et al., 2008). Applying this technique to MuHV-4 identified a role
for CD11c+ cells in LN colonization but not subsequent spread
to the spleen (Gaspar et al., 2011). In lysM-cre mice, which
express cre recombinase mainly in mature macrophages and
granulocytes (Clausen et al., 1999), the same floxed virus
(MHV-loxP-eCFP) showed minimal recombination in LN after
10 days and significant recombination in the spleen but not LN
after 14 days (Figure 1A). Thus, lysMhi cells played little role in
virus passage to LN but a significant role in passage from LN
to spleen. After 17 days recombination was also seen in LN, pre-
sumably reflecting splenic B cell recirculation, as by this time
there is generalized lympadenopathy.
The loxP sites of MHV-loxP-eCFP incorporate a mutated
spacer region that CD11c-cre mice recombine with only modest
efficiency (Gaspar et al., 2011), and the low cre expression ofHost & Microbe 15, 457–470, April 9, 2014 ª2014 Elsevier Inc. 457
Figure 1. MuHV-4 Passes from LNs to Spleen via a LysM+ Cell
(A) We infected LysM-cre mice i.n. with MHV-loxP-eCFP, which expresses eCFP from an intergenic viral M3 promoter. Cre recombinase removes the eCFP
coding sequence via flanking loxP sites.
(B) Viruses recovered from LN and spleens by infectious center assay were scored as eCFP+ or eCFP under ultraviolet illumination. Recombination rate is the
percentage of infectious centers that were eCFP negative. Circles show individual mice, crosses showmeans. ND = titers too low for reliable assay. Dashed lines
show the detection limit for recombination (2 3 eCFP plaque frequency of nontransgenic controls).
(C) Total infectious center assay titers.
(D) We infected LysM-cre mice i.n. with MHV-RG, which expresses loxP-flanked mCherry upstream of eGFP. Cre converts it from mCherry+eGFP (red) to
mCherry-eGFP+ (green).
(E) Viruses recovered from LN and spleens by infectious center assay were typed as red or green under ultraviolet illumination. Recombination rate (%) = 1003
green plaques/(green + red). No MHV-RG from nontransgenic controls was eGFP+.
(F) Total infectious center assay titers. The dashed lines show lower detection limits.
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gHV Infection in the Marginal ZonelysM-cre DCs (Clausen et al., 1999) was evidently insufficient
to recombine them en route to LN (Figure 1A). MHV-RG uses
different loxP sites and is recombined more efficiently, fluoro-
chrome expression switching from red to green (Frederico et al.,
2012). It showed substantial switching in lysM-cre LN 8 days after
i.n. infection (Figure 1B). Individual mice vary in lysM expression
(Hume,2011), andgroups rarely exceededameanof 80%recom-
bination (Figure 1B), so the day 8 recombination was already
close to maximal, and neither spleens nor LN sampled at day 16458 Cell Host & Microbe 15, 457–470, April 9, 2014 ª2014 Elsevier Inshowed significantlymore. Thus, en route to LNMuHV-4 infected
lysMlo cells that in lysM-cre mice recombined MHV-RG but
not MHV-loxP-eCFP; then, en route to the spleen, it infected
lysMhi cells that also recombined MHV-loxP-eCFP.
In Situ Fluorochrome Switching Shows Macrophage
Infection before B Cell Infection
I.n. MuHV-4 replicates in epithelial cells and LNs before reaching
the spleen. The consequent achronicity of splenic infectionc.
Figure 2. MuHV-4 Infects LysM+ Splenic Macrophages before B Cells
(A) We infected LysM-cre mice i.p. with MHV-RG, and 4 days later stained spleen sections for mCherry (red) and CD169 or MARCO (white). Nuclei were stained
with DAPI (blue). Arrows show red+ cells in the MZ. Scale bar = 50 mm. Equivalent results were obtained in six mice.
(B) Higher-magnification MZ images show red+CD169+ and red+MARCO+ macrophages (arrows). Dashed lines mark MZ/WP borders.
(C) We infected mice as in (A) and 4 days later stained sections for mCherry (red), IgD (white), and IgM (cyan). Nuclei were stained with DAPI (blue). Arrows show
mCherry+ cells. None was IgM+ or IgD+. Equivalent results were obtained in six mice.
(D) We infected mice as in (A) and 8 days later stained spleen sections for mCherry (red), IgM (cyan), and IgD (white)—or for eGFP (green), IgM (red), and IgD
(white). Again, no mCherry+ cells were IgM+ or IgD+, but some eGFP+ MZ cells were IgM+IgD+ (arrow). Equivalent results were obtained in 6 mice.
(E) Further examples of eGFP+IgM+ cells in the MZ (arrows). Figure 2, related to Figures S1 and S2.
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Figure 3. Only Replication-Competent MuHV-4 Reaches B Cells
(A–D) Examples of splenic infection by eGFP+ MuHV-4. In (A), we infected C57BL/6J mice i.p. with EF1a-eGFPMuHV-4, and 4 days later stained spleen sections
for eGFP (green) and IgM (red), plus either MARCO (MZmacrophages), CD169 (MZmetallophilic macrophages), IgD (follicular B cells), or MAdCAM-1 (endothelial
cells) (white). Nuclei were stained with DAPI (blue). Dashed lines show MZ/WP boundaries. Scale bars = 50 mm. Upper panels show the overall staining distri-
bution; lower panels show the boxed regions at higher magnification. Arrows show example eGFP+ cells. The insets show examples of eGFP+ macrophages
contacting IgM+ B cells in the MZ. In (B), mice infected as in (A) were analyzed after 8 days. Most eGFP+ cells were now in the WP and IgD+. Arrows in the IgD
column show examples, as does the inset. Arrows in the MARCO column show IgM+eGFP+ MZ B cells. In (C), we infected C57BL/6J mice i.p. with replication-
deficient (ORF50-) EF1a-eGFP MuHV-4, and 4 days later we analyzed spleen sections as in (A) Arrows and insets show example eGFP+ cells. None was IgM+ or
IgD+. In (D), mice infected as in (C) were analyzed after 8 days. EGFP+ cells remained in the MZ and were mostly CD169+ or MARCO+. None was IgM+ or IgD+.
(legend continued on next page)
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also intraperitoneal (i.p.) virus inoculation. MHV-RG recovered
from lysM-cre spleens 6 days later showed 61.5% ± 6.9%
recombination (mean ± SD, 6 mice), so lysM+ cells again
provided an important gateway.
Blood enters the murine spleen via marginal sinuses, passing
MZ metallophilic (CD169+) and MZ (MARCO+) macrophages
to reach F4/80+ red pulp (RP) macrophages (Figure S1). LysM-
cre x Ai6 reporter mice, in which cre turns on ZsGreen production
(Madisen et al., 2010), showed fluorescence in all these
populations (Figure S2). To identify the cells responsible for
MHV-RG recombination, we visualized it in situ. In this setting
cre+ cells infected by native MHV-RG can be mCherry+, but
downstream infected cells should be eGFP+. Four days after
i.p. infection, lysM-cre spleen sections showed mCherry+ but
not eGFP+ cells (Figure 2A). Greater than 95% of the mCherry+
cells were in the MZ: 45.7% ± 9.5% were CD169+ and
31.7% ± 7.9% were MARCO+ (mean ± SD, nine sections from
three mice) (Figure 2B). No mCherry+ cells were B cells (IgD+
or IgM+) (Figure 2C); by distribution and morphology, all were
macrophages.
After 8 days (Figures 2D and 2E) 25.4% ± 3.9% of fluorescent
cells in theMZwere eGFP+ rather thanmCherry+. Again >85%of
mCherry+ cells were CD169+ or MARCO+ and none was IgD+ or
IgM+ (Figure 2D, upper panels), but 25.2%± 9.4%of eGFP+ cells
were IgMhi (Figures 2D and 2E). Thus, i.p. virus reached splenic
MZ macrophages without prior passage through a lysM+ cell
(at day 4 splenic macrophages were all mCherry+eGFP), then
gained access to IgM+ MZ B cells (as these were not fluorescent
until day 8 and were mCherryeGFP+).
Viral eGFP Expression Shows MZ Infection before WP
Infection
The M3 promoter driving MHV-RG fluorochrome expression is
active mainly in lytic infection. To identify also latent infection,
we tracked eGFP expression from a viral EF1a promoter (Freder-
ico et al., 2012). Replication-competent or replication-deficient
(ORF50) versions of this virus were given i.p. to mice, and
spleen sections stained 4 and 8 days later for eGFP, macro-
phages (MARCO, CD169), B cells (IgD, IgM), and endothelial
cells (MAdCAM-1) (Figure 3). Day 4 eGFP expression was largely
confined to the MZ, and most eGFP+ cells were CD169+ or
MARCO+ (Figures 3A and 3E). Close apposition was evident
between eGFP+ macrophages and IgMhi B cells (Figure 3A,
insets), consistent with infection transfer, and by day 8 (Figures
3B and 3F) significantly more eGFP+ cells were B cells and inside
WP follicles (p < 0.001). Some MAdCAM-1+ endothelial cells
were also eGFP+ (Figure 3A). However, there were 30–40
eGFP+ macrophages and only 0–1 eGFP+MAdCAM-1+ cells
per follicle, so infection moved mostly from macrophages to B
cells. Comparing fluorochrome expression from M3 (Figure 2)
and EF1a promoters (Figure 3) suggested that a substantial
fraction of MZ infection was lytic, whereas most WP infection
was latent (or abortive).(E–H) Quantitation across multiple sections. In (E) and (F), mice were infected and
MZs for each of five mice. Bars show mean ± SEM. In (E), eGFP+ cells were sco
eGFP+ cells were scored by their position relative to theMAdCAM-1+ endothelial c
as in (C) and (D) and scored as in (E) and (F).
CellReplication-Deficient MuHV-4 Is Arrested in MZ
Macrophages
ORF50MuHV-4 fails to replicate without complementation and
so marks only the first infected cells. Four days after i.p.
EF1a-eGFP+ORF50 MuHV-4, >95% of splenic eGFP+ cells
were CD169+ or MARCO+ macrophages and none was IgM+ or
IgD+ (Figures 3C and 3G). Some MAdCAM-1+ endothelial cells
were eGFP+ but, again, they were sparse (0–1 per follicle). Day
8, infection remained overwhelmingly in MZ macrophages (Fig-
ures 3D and 3H; p < 0.001). Thus, i.p. infection directly reached
MZ macrophages and not B cells.Functional Evidence that Splenic Macrophage Infection
Precedes Splenic B Cell Infection
To establish functionally that macrophage infection precedes
B cell infection, we gave MHV-RG i.p. to lysM-cre or CD19-cre
mice, recovered viruses by infectious center assay, and typed
them for recombination (Figure 4A). At day 1, CD19-cre spleens
yielded no eGFP+ virus, while that from lysM-cre spleens was
>25% eGFP+. Virus from lysM-cre peritoneal washes also
switched, but this did not account for the splenic switching, as
i.p. virus reached splenic macrophages directly (Figure 3)
without prior recombination (Figure 2). CD19-cre spleens yielded
>50%eGFP+ virus at day 8, so thesemice efficiently recombined
MHV-RG once B cells were infected. Therefore, splenic B cells
were not infected until after splenic macrophages.MZ B Cells Take MuHV-4 to WP Follicles
After passing from MZ macrophages to MZ B cells, EF1a-eGFP
MuHV-4 entered the WP (Figure 3B). A cellular vehicle for this
movement seemed likely, as cell-free virions would follow MZ
blood flow to the RP (Figure S1). Macrophage migration seemed
unlikely, as eGFP+CD169+ and eGFP+MARCO+ cells remained
in the MZ and eGFP+F4/80+ macrophages remained in the RP
(Figure 4B). However, CD1d+eGFP+ cells were abundant in the
MZ at day 4 (Figures 4C and 4D), and in theWP at day 8, whereas
no WP cells were CD1d+ at day 4—or in naive mice (data not
shown). These were therefore a plausible candidate for virus
transfer. MZ B cells express CD1d (Makowska et al., 1999),
can transport antigens to the WP (Lopes-Carvalho and Kearney,
2004; Cerutti et al., 2013), and communicated with infected MZ
macrophages (Figure 3). The CD1d+eGFP+ cells in the MZ at
day 4 were IgMhi (Figure 4D). Those in the WP at day 8 stained
poorly for IgM, suggesting that they may have differentiated
into plasma cells, a key gHV reactivation trigger (Laichalk and
Thorley-Lawson, 2005; Liang et al., 2009).
We sought functional evidence for MZ B cell involvement
in infection spread by driving them prematurely into the WP
with the sphingosine-1-phosphate receptor agonist FTY720
(Cinamon et al., 2004). Mice treated with drug or not were given
i.p. EF1a-eGFP MuHV-4 (Figures 4E and 4F). At day 4, drug-
treated and untreated mice showed similar numbers of eGFP+
MZ macrophages, but at day 8 drug-treated mice hadanalyzed as in (A) and (B). EGFP+ cells were counted for at least five follicles/
red as MZ macrophages (CD169+ or MARCO+) or B cells (IgM+ or IgD+). In (F),
ells separating theWP andMZ. In (G) and (H), mice were infected and analyzed
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Figure 4. CD19+ B Cells Are Infected after LysM+ Myeloid Cells and Then Relocate to the WP
(A) We infected LysM-cre, CD19-cre, and C57BL/6J mice i.p. with MuHV-RG. Viruses were recovered from spleens and peritoneal washes by infectious center
assay 1 or 8 days later and scored as red (native) or green (recombined). Recombination rate = 1003 green / (green + red). Circles show individual mice, crosses
show means. At day 1, recombined viruses were recovered from lysM-cre but not CD19-cre mice. At day 8 recombined viruses were recovered from CD19-cre
but not C57BL/6J mice.
(B) We infected C57BL/6J mice i.p. with EF1a-eGFP MuHV-4, and 4 and 8 days later stained spleen sections for eGFP (green), IgM (red), and macrophages (F4/
80, white). Nuclei were stained with DAPI (blue). The middle panels show the day 4 MZ and RP boxed regions at higher magnification. Arrows show eGFP+F4/80+
macrophages. By day 8, eGFP wasmainly in theWP; F4/80 staining remained in the MZ / RP. Scale bars = 50 mm. Equivalent results were obtained in three mice.
(legend continued on next page)
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MZ B cell role in MZ to WP MuHV-4 transfer.
Virus Transfer via Follicular DCs
MuHV-4 persists in GC-derived memory B cells (Willer and
Speck, 2003), and at day 8 of i.p. infection eGFP+PNA+ cells
were evident in splenic WP follicles (Figures 5A and 5B). MZ B
cells can enter GCs (Cerutti et al., 2013). However, this is more
commonly a function of follicular B cells, and as these also
harbor MuHV-4 genomes (Marques et al., 2003), they seemed
a more likely route to GC exploitation. MZ and follicular B cells
are not known to interact, but both interact with follicular DCs.
After EF1a-eGFP MuHV-4 inoculation, CR1/2+ follicular DCs
remained eGFP (Figures 5C–5E). However, they were closely
associated with eGFP+ WP B cells (Figure 5D), and at day 4,
virion antigens were evident on CR1/2+ DC processes (Fig-
ure 5E). None was seen on the follicular DCs of mice infected
with replication-deficient (ORF50) MuHV-4, so they were a
product of lytic spread. Thus, MuHV-4 produced by MZ B cells
appeared to reach GC B cells via follicular DCs. The uniform
small size of viral antigen+ particles on DCs (<1 mm diameter)
suggested that many of these were virions rather than infected
cell debris.
Intranasal Virus Infects the Spleen Similarly to
Intraperitoneal Virus
Nine days after i.n. EF1a-eGFPMuHV-4, when infection first rea-
ches the spleen, eGFP+CD19+ splenic B cells showed higher
CD35 expression and lower CD23 expression than eGFP-CD19+
cells, consistent with MZ B cells (CD19+CD23loCD35hi) being an
early target (Figure 5F). Spleen sections showed eGFP+CD169+
MZ macrophages (Figure 5G), IgMhieGFP+ MZ B cells,
B220+eGFP+ WP B cells (Figure 5H), and the intermediate step
of eGFP+IgMhi WP B cells (Figure 5I). Thus, i.p. and i.n. infections
showed the same component steps of splenic colonization.
Because i.n. virus must traverse the olfactory epithelium and
LNs, splenic infection was less synchronous and its different
stages consequently less distinct—when eGFP+ cells were
abundant in most MZs, some follicles already showed spread
to the WP. Nonetheless, MZ involvement was clear.
A Lack of MZ B Cells Impairs Splenic Infection by
Intranasal and Intraperitoneal MuHV-4
We next sought functional evidence for MZ involvement in
splenic colonization by i.n. MuHV-4. As FTY720 disrupts both
spleen and LN lymphocyte traffic (Cinamon et al., 2004), we
instead used CD19/ mice as a MZ B cell-deficient mutant
(Martin and Kearney, 2000) that otherwise makes normal acute
responses to viral infection (Fehr et al., 1998). Nose and lung in-(C)We infectedmice as in (B) and stained spleens 4 or 8 days later for eGFP (green
eGFP was in the MZ and day 8 eGFP in the WP. Equivalent results were obtaine
(D) The boxed regions of (C) at higher magnification with separate channels. Arrow
WP at day 8.
(E) Mice treated or not with the sphingosine-1-phosphate receptor agonist FTY72
sections were stained for eGFP (green), IgM (red), and CD169 (white). Nuclei were
cells in theMZ. Arrows show eGFP+CD169+MZmacrophages. At day 8most eGF
in the MZ (arrows).
(F) Mean ± SEM counts per section, scoring eGFP+ cells as inside or outside the
Cellfections were comparable between CD19/ and CD19+/+ mice
(Figure 6A). However, CD19/ lymphoid infections were signif-
icantly reduced (Figure 6B), as were CD19/ viral genome loads
(Figure 6C). The reduction in infectious centers titers was signif-
icantly greater for spleens (p < 0.01), and immunostaining for viral
eGFP at day 10 (Figure 6D) showed B cell infection in CD19+/+
and CD19/ LNs and CD19+/+ but not CD19/ spleens.
CD19 deficiency also impaired spleen infection (but not
peritoneal exudate cell infection) by i.p. virus, as measured by
infectious center assay (Figure 6E), viral DNA load (Figure 6F),
and immunostaining (Figure 6G). Thus, CD19/ mice showed
a general defect in B cell infection, and a particular defect in
splenic infection, consistent with an important role here for MZ
B cells.
B Cell Colonization Depends on Virus-Driven
Intercellular Spread
The close parallels between MuHV-4 spread and host immune
pathways suggested that the virus might be a merely passive
passenger. To test this, we analyzed MuHV-4 lacking ORF27,
which encodes a glycoprotein necessary for efficient intercellular
spread (May et al., 2005) and conserved in KSHV (ORF27) and
EBV (BDLF2). After i.p. inoculation, ORF27 infectious centers
were similar to ORF27+ in peritoneal exudate cells but reduced
in spleens (Figure 7A). Splenic viral genome loads were also
reduced (Figure 7B). A similar phenotype was observed with
an independent ORF27mutant, while a revertant virus replicated
like wild-type (Figure 7C). We determined the long-term conse-
quences of ORF27 deficiency by giving mice 3:1 mixtures of
marker-distinguished ORF27 and ORF27+ viruses i.p., then
marker-typing splenic virus 1month later (Figure 7D). Recovered
splenic virus was consistently enriched for ORF27+. Thus, a lack
of ORF27 impaired both acute and long-term splenic infection.
Splenic sections (Figures 7E and 7F) showed that both
ORF27eGFP+ and ORF27+eGFP+ viruses colonized MZ
macrophages by day 4, but only ORF27+ efficiently formed
eGFP+ WP follicles by day 8: ORF27 virus remained largely in
the MZ. Thus, a lack of ORF27 did not impair virus entry into
macrophages, consistent with normal peritoneal exudate titers
(Figure 7A), but impaired subsequent spread to WP B cells.
Therefore, MuHV-4 was not just a passive participant in inter-
cellular exchanges but actively promoted them to enhance
host colonization.
DISCUSSION
Lymphocytes must confront invading pathogens, but a capacity
for proliferation and dissemination makes their own infection a
potential hazard. Myeloid cells consequently play an important,), CD1d (white), and IgM (red). Nuclei were stainedwith DAPI (blue). Again, day 4
d in six mice.
s show IgM+CD1d+eGFP+ cells in theMZ at day 4 and eGFP+CD1d+ cells in the
0 to dislocate MZ B cells prematurely to the WP were infected as in (B). Spleen
stained with DAPI (blue). At day 4, both treated and untreated mice had eGFP+
P+ cells of untreatedmice were in theWP, while those of treatedmice remained
WP for three to four sections from each of three mice per group.
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Figure 5. Virus Transfer to Follicular B Cells via Follicular DCs and Similar Infection by Intranasal MuHV-4
(A) We infected C57BL/6J mice i.p. with EF1a-eGFP MuHV-4 and 4 or 8 days later stained spleen sections for eGFP (green) and with PNA (white). Nuclei were
stained with DAPI (blue). Dashed lines showWP/MZ boundaries. At day 4, most eGFP+ cells were in the MZ, and fewWP cells were PNA+; at day 8, most eGFP+
cells were in the WP and many WP cells were PNA+. Scale bars = 50 mm. Equivalent results were obtained in three mice.
(B) A higher magnification view of the WP at day 8, with eGFP+PNA+ cells (arrows).
(C and D) We then infected mice as in (A), and 4 or 8 days later, stained spleen sections (C and D) for complement receptors 1/2 (CR1/2, white), which are highly
expressed on follicular DCs, and for either IgM (red) plus eGFP (green) or for viral antigens (MuHV-4, red). Nuclei were stainedwith DAPI (blue). Scale bars = 50 mm.
Dashed lines outline WP follicles. Equivalent results were obtained in three mice. Arrows in (C) show eGFP+ and MuHV-4+ MZ cells with morphologies typical of
macrophages. (D) shows eGFP+ B cells closely associated with CR1/2hi eGFP follicular DCs. (E) The left-hand panels show the boxed region of (C) at higher
magnification, with MuHV-4 antigens on CR1/2+ DC processes. The right-hand panels show no viral antigens on the DCs of a mouse infected with replication-
deficient MuHV-4 (ORF50).
(legend continued on next page)
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colonize lymphocytes nonetheless. How has been unclear.
MuHV-4 spread by serial virus exchange along normal immune
communications. An important implication is that appropriate
immunity to lytic antigens could restrict gHV dissemination.
I.n. MuHV-4 reaches the SCLN via aCD11c+ cell (Gaspar et al.,
2011). Essentially, all the virus recoverable from SCLN has also
passed through a B cell (Frederico et al., 2012) and i.n. virus
does not reach the spleens of B cell-deficient mice (Usherwood
et al., 1996). Therefore, SCLN B cell infection is the next step.
The next anatomical target is the spleen, where B cell infection
again predominates. However, infected splenic B cells seem
not to descend directly from SCLN B cells, andMuHV-4 reached
splenic follicular B cells only via MZ macrophages, MZ B cells,
and follicular DCs. This would explain why gHV infectious mono-
nucleosis elicits strong T cell responses to lytic antigens (Callan
et al., 1996; Stevenson et al., 1999). Spread via specialized
macrophages is consistent with their emerging role in antigen
presentation to B cells (Junt et al., 2007; Carrasco and Batista,
2007; Phan et al., 2009).
To infect MZ macrophages, MuHV-4 must reactivate from
SCLN B cells. Reactivation is associated with plasma cell differ-
entiation. Potentially, this could occur in the MZ, but while MZ B
cells differentiate here, it is not classically a differentiation site for
LN-derivedmemory B cells. Also, a freely circulating B cell would
traverse the spleen >300 times a day (Chen and Kaufman, 1996),
so in the long term, a tendency to reactivate here would severely
deplete the latent pool. LN medullary cords are a prominent site
of plasma cell differentiation (Fooksman et al., 2010), and acute
viral lytic gene expression is evident in the SCLN (Figure S3).
Thus, we hypothesize that MuHV-4 reaches the spleen after
being shed into the efferent lymph by reactivating SCLN B cells.
We detect cell-free MuHV-4 DNA in only 40%–50% of acute
serum samples (data not shown), but at this time virus loads
are still low—they are amplified primarily in the spleen—and
released virions may have only a short half-life in the blood, mak-
ing detection difficult. Acute viremia consistent with vascular
spread is well known for EBV (Gan et al., 1994).
In passing fromMZmacrophages to MZ B cells, follicular DCs,
and thenGCBcells,MuHV-4 followednormal immunecommuni-
cation pathways. Direct spread from MZ macrophages to follic-
ular B cells (Arnon et al., 2013) is also possible, but MZ B cells
seemed to provide the main route. MuHV-4 amplified these ex-
changes with ORF27—which promotes intercellular virus spread
via fine, virus-laden actin protrusions (Gill et al., 2008). Diverse
actin-based intercellular connections have been identified for vi-
rusesspreading in vitro (Xuet al., 2009), andMuHV-4also induces(F) We infected C57BL/6J mice i.n. with EF1a-eGFPMuHV-4 and 9 days later anal
cytometry. The numbers show mean ± SD percentages of gated cells in each qu
CD35loCD23hi (follicular) B cells (p < 0.0001) and significantly higher in CD35hiCD
(G) We infected mice as in (F) and 9 days later stained spleen sections for eGFP
image shows the overall distribution of eGFP staining (scale bar = 50 mm). The right
eGFP+CD169+ MZ macrophages. Equivalent results were obtained in six mice.
(H) We infectedmice as in (F) and 9 days later stained spleen sections for eGFP (gr
hand image shows the overall distribution of staining (scale bar = 50 mm); the rig
eGFP+IgM+ MZ B cells and eGFP+B220+ follicular B cells. Equivalent results wer
(I)We infectedmice as in (F) and 9 days later stained spleen sections for eGFP (gre
left-hand panel shows the overall distribution of eGFP staining (scale bar = 50 mm
show eGFP+IgMhi cells in the WP. Equivalent results were obtained in 6 mice. Fi
Celllarge-scale cytoskeletal reorganization in infected myeloid cells
(Smith et al., 2007) consistent with the envelopment of MZB cells
by infected CD169+ MZ macrophages. (ORF27-induced protru-
sions are much finer and visible only at higher magnification.)
Follicular DCs appeared to transfer virus without becoming
infected, analogous to their presentation of immune complexes
to GC B cells. Similar transfers have been described in vitro
(Piguet and Steinman, 2007). Follicular DCs— like in vitro acti-
vated DCs (Smith et al., 2007)—may resist infection because
they poorly transport antigens to late endosomes (Chen et al.,
1978), the site of MuHV-4 membrane fusion (Gillet et al., 2008).
Transferred virions could still acquire B cell tropism (Frederico
et al., 2012), as the key glycoprotein conformation changes
occur in early endosomes (Glauser et al., 2012).
EBV drives splenomegaly and exploits GCs, and KSHV infects
GC macrophages (Valmary et al., 2005). However, the precise
paths these viruses follow must remain speculative: human
spleens also capture and respond to blood-borne antigens (Weill
et al., 2009), but their marginal sinuses and associated
macrophages occupy a peri-follicular zone rather than the MZ
(Steiniger et al., 1997). EBV lytic spread has been inferred from
histological analysis of infected tonsils (Kurth et al., 2000), but
clinical presentation occurs relatively late in infection, and con-
clusions must be drawn from single time points. Our data
showed events changing dramatically with time; serial tracking,
virus marking, and a replication-deficient mutant were all neces-
sary to understand a highly complex process.
In vitro EBV analysis has concentrated on cell-free virions
(Borza and Hutt-Fletcher, 2002); in vivo infection may pass
more from cell to cell. This is hard for antibody to block, possibly
explaining the failure of gp350-specific antibodies to reduce EBV
infection rates (Sokal et al., 2007). Targeting the cells that collect
virions for transfer to B cells could work better. For MuHV-4 this
was myeloid cells. Myeloid infection has been reported also for
EBV (Savard et al., 2000; Guerreiro-Cacais et al., 2004; Walling
et al., 2007). MuHV-4 elicits antibody responses that neutralize
myeloid infection poorly and instead enhance it via IgG Fc recep-
tor binding (Rosa et al., 2007; Gillet et al., 2007a). However
vaccine-induced antibodies to gH/gL can block infection (Gillet
et al., 2007b). Thus, understanding MuHV-4 dissemination sug-
gests a possible approach to gHV infection control.EXPERIMENTAL PROCEDURES
Mice
BALB/c, C57BL/6J (Harlan UK), LysM-cre (Jackson Laboratories) (Clausen
et al., 1999), and CD19-cre mice (kindly provided by M. Turner, Babrahamyzed eGFP and eGFP+ B cells (CD19+) for CD23 and CD35 expression by flow
adrant for six mice in two experiments. EGFP+ rates were significantly lower in
23lo (MZ) B cells (p < 0.003).
(green) and CD169 (white). Nuclei were stained with DAPI (blue). The left-hand
-hand panels show the boxed regions at highermagnification, with examples of
een), B220 (white), and IgM (red). Nuclei were stained with DAPI (blue). The left-
ht-hand panels show the boxed regions at higher magnification. Arrows show
e obtained in six mice.
en), MAdCAM-1 (white), and IgM (red). Nuclei were stainedwith DAPI (blue). The
); the right-hand panel shows the boxed region at higher magnification. Arrows
gure 5, related to Figure S3.
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Figure 6. CD19 Deficiency Severely Compromises MuHV-4 Host Colonization
(A) We infected wild-type or CD19/ mice i.n. with MuHV-4 and 7 days later measured infectious virus in noses and lungs by plaque assay. Circles show
individual mice; crosses show means. Horizontal bars show statistical comparisons.
(B) We infected mice as in (A) and measured viral loads in superficial cervical lymph nodes (SCLN), mediastinal lymph nodes (MLN), and spleens by infectious
center assay 7, 10, and 13 days later.
(C) Lymphoid tissue of the day 10 and 13mice in (B) was assayed for viral genomes (M2) by Q-PCR. Results are normalized by cellular DNA copy numbers (APRT).
(D) We infected wild-type and CD19/mice i.n. with EF1a-eGFP MuHV-4 and stained LN and spleens 10 days later for eGFP (green), IgM (red), and IgD (white).
Nuclei were stainedwith DAPI (blue). Dashed lines outline B cell follicles. Scale bars = 50 mm. Arrows show eGFP+ cells, whichwere absent fromCD19/ spleens.
(E) We infected wild-type or CD19/ mice i.p. with EF1a-eGFP MuHV4 and recovered viruses 8 days later by infectious center assay.
(F) We infected mice as in (E) and measured splenic viral genome loads (M2) by Q-PCR, normalized by cellular DNA copy numbers (APRT).
(G) We infected mice as in (E) and stained spleen sections 8 days later for eGFP (green), IgM (red), and CD169 (white). Nuclei were stained with DAPI (blue).
Dashed lines outline WP follicles. Scale bar = 50 mm.
(H) We counted eGFP+ cells on spleen sections and scored them as within or the WP or not (mean ± SEM for five mice, counting 15 follicles each).
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Figure 7. Efficient GC Colonization Requires the MuHV-4 ORF27
(A) We infected C57BL/6Jmice i.p. with ORF27+ (WT) or ORF27FRT (27) EF1a-eGFP+MuHV-4, then titered peritoneal exudate cell (PECs) and spleens for virus
by infectious center assay 3 and 6 days later. Circles show individual mice; crosses show means. WT and ORF27- PEC titers were not significantly different (p >
0.15), but ORF27 spleen titers were significantly reduced (p < 0.01).
(B) Splenic viral genome loads measured by Q-PCR also showed a significant, ORF27-dependent reduction (p < 0.03).
(C)We infected C57BL/6Jmice i.p. with ORF27+ (WT or revertant of 27-FRT =REV) or ORF27 (27FRT or 27STOP) viruses—this timewithout EF1a-eGFP—and
measured splenic viral loads by infectious center assay 4 and 8 days later. ORF27 viruses showed significantly lower titers at both day 4 (p < 0.002) and day 8 (p <
0.0002).
(D)Wemixed 27FRT EF1a-eGFP+MuHV-4with the unlabelled revertant (ORF27+) (3:1 ratio, left-hand panel), or 27STOPMuHV-4with the EF1a-eGFP+WT (3:1
ratio, right-hand panel), then infected mice i.p. (total 105 p.f.u.), and 1 month later typed the viruses recovered by infectious center assay as eGFP+ or eGFP.
Circles show the percentage of eGFP of virus recovered from each mouse. Crosses show means. Because eGFP fluorescence makes plaques more obvious,
eGFP+ plaque counts could exceed morphological plaque counts; any counting bias was controlled by having the eGFP tag on ORF27 virus in one mixture and
ORF27+ in the other. Dashed lines show percentage of eGFP of the input virus. For each infection the recoveredORF27 proportionwas significantly less than the
input (p < 0.001).
(E)We infected C57BL/6Jmice i.p. with EF1a-eGFP+ORF27FRTMuHV-4 or its ORF27+ revertant (REV). Four and eight days later we stained spleen sections for
eGFP (green), IgD (white), and IgM (red). Nuclei were stained with DAPI (blue). Day 4 arrows show infected MZ macrophages (eGFP+IgDIgM). Day 8 shows
abundant ORF27+eGFP+ infection in the splenic WP and limited ORF27eGFP+ infection.
(F) Mean ± SD. WP infection rates from three sections each of three mice per group. At day 8, ORF27 WP infection was significantly less than that of WT or
revertant viruses (p < 0.01).
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gHV Infection in the Marginal ZoneInstitute) (Rickert et al., 1997) were infected with MuHV-4 when 6–12 weeks
old, either i.n. in 30 ml under isoflurane anesthesia (104 p.f.u.) or i.p. in 100 m1
(106 p.f.u.). CD19-cre disrupts CD19 (Rickert et al., 1997), so we used
CD19+/cre mice for floxed virus tracking and CD19cre/cre mice as CD19 knock-
outs. Ai6-ZSgreen1 reporter mice (Madisen et al., 2010) were provided by S.
Efstathiou (University of Cambridge, Cambridge, UK). For luciferase imaging,
mice were given luciferin i.p. (2 mg/mouse) and scanned in an IVIS Lumina
(Caliper Life Sciences). To empty the MZ of B cells, mice were injected i.p.
with FTY720 (Cayman Chemical) (for i.p. infections, 2 mg/kg the day before
and 1 mg/kg/day thereafter; for i.n. infections, 2 mg/kg on the day of infection
and 1mg/kg every other day thereafter). All animal experiments were approved
by the Cambridge University Ethical Review Board (Project License 80/2538).
Cells and Viruses
BHK-21 (American Type Culture Collection CCL-10), 3T3-CRE (Stevenson
et al., 2002), and 3T3-ORF50 cells (Milho et al., 2009) were grown in Dulbec-
co’s Modified Eagle’s Medium, 2 mM glutamine, 100 U/ml penicillin,
100 mg/ml streptomycin, and 10% fetal calf serum. MHV-LUC, MHV-LoxP-
eCFP (Gaspar et al., 2011), MHV-RG, and ORF50+ (wild-type) (Frederico
et al., 2012) and ORF50 (replication-deficient) (Milho et al., 2009) versions
of EF1a-eGFP MuHV-4 have been described. ORF27-deficient (27FRT,
27STOP) and 27FRT revertant (27+REV) BACs (May et al., 2005) were com-
bined with the EF1a-eGFP reporter construct and virus recovered by trans-
fecting BHK-21 cells. The BAC cassette was removed by virus passage
through 3T3-CRE cells. ORF50 MuHV-4 was grown and titered on 3T3-
ORF50 cells. Other viruses were grown and titered on BHK-21 cells. Virions
were harvested from infected cell supernatants by ultracentrifugation
(35,000 g, 90 min), and cell debris was removed by low-speed centrifugation
(500 g, 5 min).
Infectivity Assays
Infectious virus was measured by plaque assay. Virus stocks or organ homog-
enates were incubated with BHK-21 cells (2 hr, 37C), then overlaid with 0.3%
carboxymethylcellulose. Four days later, the cells were fixed (4% formalde-
hyde) and stained (0.1% toluidine blue) for plaque counting. Latent plus infec-
tious virus was measured by infectious center assay: single-cell suspensions
of explanted spleens and LNs were cocultured with BHK-21 cells, then fixed
and stained after 4 days. Infectious virus in lymphoid tissue is typically <5%
of the total recoverable virus, so the infectious center assay measures mainly
latency. To assay fluorochrome switching by MHV-RG or MHV-LoxP-eCFP,
plaque and infectious center assays were performed at limiting dilution in
96-well plates (12–24 wells per dilution), and plaques scored as red, green,
or eCFP fluorescent under ultraviolet illumination. Statistical comparisons
were by Student’s two-tailed unpaired t test.
Viral Genome Quantitation
MuHV-4 genomic coordinates 4166–4252 were amplified by PCR (Rotor Gene
3000, Corbett Research) from tissue DNA, quantitated by fluorescent probe
hybridization (coordinates 4218–4189), and converted to genome copies by
comparison with cloned DNA amplified in parallel. Cellular DNA was quanti-
tated in the same reaction by amplifying part of the adenosine phosphoribosyl
transferase gene, again with probe hybridization and template dilutions ampli-
fied in parallel. Viral DNA loads were then normalized by cellular DNA loads
(Gaspar et al., 2011).
Immunohistochemistry
Organs were fixed in PBS/4% formaldehyde (24 hr, 4C), dehydrated in 70%
ethanol, and embedded in paraffin. Sections of 7 mm were de-waxed in
xylene and hydrated in water/ethanol. Endogenous peroxidase activity was
quenched in PBS/3% H2O2 (10 min, 23
C). Sections were blocked with
Avidin/Biotin Blocking Kit (Vector Laboratories) and PBS/2% BSA/2% serum
of the secondary antibody species (1 hr, 23C). B cells were detected with
anti-B220 (RA3-6B2, Abcam), RP macrophages with anti-F4/80 (Cl:A3-1),
MZ macrophages with anti-CD169 (3D6.112, Serotec), and MuHV-4 with a
rabbit pAb kindly provided by Dr. L. Gillet (University of Lie`ge). After incubation
with primary antibodies (16 hr, 23C), sections were washed 33 in PBS, incu-
bated with biotinylated rabbit anti-rat IgG pAb or biotinylated goat anti-rabbit
IgG pAb (30 min, 23C, Vector), washed 33 in PBS, incubated with Vectastain468 Cell Host & Microbe 15, 457–470, April 9, 2014 ª2014 Elsevier InElite ABC Peroxidase system (30 min, 23C), washed 33 in PBS, and then
incubated with ImmPACT DAB substrate (5min, 23C, Vector). Sections
were counterstained with Mayer’s Hemalum, dehydrated in ethanol, and
mounted in DPX.
Immunofluorescence
Organs were fixed in 1% formaldehyde/10 mM sodium periodate /75 mM
L-lysine (24 hr, 4C), equilibrated in 30% sucrose (18 hr, 4C), and then frozen
in OCT. Sections of 9 mm were air-dried (1 hr, 23C), blocked with 0.3% Triton
X-100/5% normal goat serum (1 hr, 23C), and then incubated (18 hr, 4C) with
primary antibodies to eGFP (rabbit pAb, Abcam), mCherry (rabbit pAb,
Badrilla), MARCO (ED31), MAdCAM-1 (MECA-367, Serotec), IgM (biotin-con-
jugated goat pAb), IgD (11-26c, Southern Biotech), CD1d (1B1), CR1/CR2
(7G6, BD Biosciences), or CD68 (FA-11, Biolegend). Antibodies to B220,
CD169, F4/80, and MuHV-4 lytic antigens were as above. Sections were
washed 33 in PBS, incubated (1 hr, 23C) with Alexa633-conjugated goat
anti-rat IgG pAb, streptavidin-conjugated Alexa568, and Alexa488- or 568-
conjugated goat anti-rabbit IgG pAb (Invitrogen), washed 33 in PBS, and
mounted in Prolong Gold + DAPI. Fluorescence was visualized with a Leica
TCS SP5 confocal microscope and analyzed with ImageJ.
Flow Cytometry
Spleen cells were harvested from mice infected with eGFP+ MuHV-4. IgG Fc
receptor binding was blocked (30 min, 4C) with rat anti-CD16/32 mAb before
staining (1 hr, 4C) with APC-conjugated anti-CD19, phycoerthyrin-conjugated
anti-CD23, and biotinylated anti-CD35 (BD Biosciences). The cells were
washed 23 in PBS, incubated (30 min, 4C) with PerCP-conjugated streptavi-
din, washed 23 in PBS, and then analyzed on a FACS Calibur.SUPPLEMENTAL INFORMATION
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